Dr. Andres Chang: Why Is It Important for You to Empower Patients?
Dr. Andres Chang: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. Dr. Andres Chang from Winship Cancer Institute of Emory University discusses his…
Dr. Jennifer Brown: Why Is It Important for You to Empower Patients?
Dr. Jennifer Brown: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. Why is it important to empower patients? CLL expert Dr. Jennifer Brown…
Dr. Daniel Ermann: Why Is It Important for You to Empower Patients?
Dr. Daniel Ermann: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. What are some methods to empower patients? CLL expert Dr. Daniel Ermann…
Dr. Catherine Coombs: Why Is It Important for You to Empower Patients?
Dr. Catherine Coombs: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. What are some ways to empower patients? CLL expert Dr. Catherine Coombs…
Dr. Megan Haymart: Why Is It Important for You to Empower Patients?
Dr. Megan Haymart: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. Why is it important to empower patients? Expert Dr. Megan Haymart from…
CLL Expert Perspectives on Current and Future Patient Care
https://vimeo.com/984718222 How does the current day and the future of chronic lymphocytic leukemia (CLL) care look? Experts Dr. Jennifer Brown from Dana-Farber Cancer Institute and Dr. Callie Coombs from the University of California, Irvine…
Managing CLL Side Effects | Innovative Strategies and Approaches
https://vimeo.com/984716940 What can chronic lymphocytic leukemia (CLL) HCPs consider for innovative ways to manage CLL side effects? Experts Dr. Jennifer Brown from Dana-Farber Cancer Institute and Dr. Callie Coombs from the University of California,…
CLL Clinical Trials for Molecularly Defined Patient Subgroups
https://vimeo.com/984713473 What’s the latest in chronic lymphocytic leukemia (CLL) clinical trials for molecularly defined patient subgroups? Experts Dr. Jennifer Brown from Dana-Farber Cancer Institute and Dr. Callie Coombs from the University of California, Irvine…
CLL Expert Updates on Diagnostic Tool and Technology Advances
https://vimeo.com/984710979 What diagnostic tool and technology advances for chronic lymphocytic leukemia (CLL) are available in clinic, and which ones are in the research setting? Experts Dr. Jennifer Brown from Dana-Farber Cancer Institute…
How Can CLL HCPs Gain More Understanding of Mutation Profiles?
https://vimeo.com/984703729 How might chronic lymphocytic leukemia (CLL) HCPs gain more understanding of mutation profiles? Experts Dr. Jennifer Brown from Dana-Farber Cancer Institute and Dr. Callie Coombs from the University of California, Irvine discuss several…
HCP Roundtable: Exploring CLL Mutations and Best Practices for Side Effect Management
https://vimeo.com/984719141 As the chronic lymphocytic leukemia (CLL) treatment landscape evolves, how can healthcare professionals deepen their understanding of mutation profiles, including the emergence of novel CLL mutations over time? What…
Dr. Jeanne Palmer: Why Is It Important for You to Empower Patients?
Dr. Jeanne Palmer: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. Why is it important to empower patients? Expert Dr. Jeanne Palmer from…